Evaluation of Antiemetic Practices for Prevention of Chemotherapy-induced Nausea and Vomiting (CINV): Results of a European Oncology Nurse Survey

被引：0
|
作者：
Dielenseger, P. [1 ]
Borjeson, S. [2 ]
Vidall, C. [3 ]
Young, A. [4 ]
Jahn, P. [5 ]
机构：
[1] Gustave Roussy Inst Oncol, Early Drug Dev, Villejuif, France
[2] Linkoping Univ, Div Nursing Sci, Dept Med & Hlth Sci, Linkoping, Sweden
[3] Alcura UK Ltd, Nursing & Governance, Northampton, England
[4] Univ Hosp Coventry & Warwickshire, Canc Res Ctr, Coventry, W Midlands, England
[5] Univ Hosp Halle Saale, Nursing Res Unit, Halle, Germany
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1552P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting (CINV) in U. S. community oncology practice: INSPIRE study
    Gilmore, James W.
    Peacock, Nancy Walker
    Gu, Anna
    Szabo, Stephen
    Rammage, Melissa
    Sharpe, Joyce
    Haislip, Sally
    Perry, Toni S.
    Boozan, Tim Lee
    Meador, Katherine
    Cao, Xiting
    Burke, Thomas A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [42] PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) WITH NEPA, THE FIRST ORAL COMBINATION ANTIEMETIC, IN PATIENTS WITH GYNECOLOGICAL CANCERS RECEIVING PLATINUM-BASED CHEMOTHERAPY
    Bosnjak, S.
    Stamatovic, L.
    Jordan, K.
    Rizzi, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 582 - 583
  • [43] Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers
    Navari, R.
    Jordan, K.
    Rapoport, B. L.
    Schnadig, I.
    Chasen, M.
    Arora, S.
    Powers, D.
    Schwartzberg, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [44] CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) AND DRIVERS OF ANTIEMETIC PRESCRIBING: RESULTS OF A QUALITATIVE IN-PRACTICE STUDY OF CLINICIANS FROM VARIOUS SETTINGS
    LeBlanc, T. W.
    D'Agostino, P.
    Ruffo, P.
    Turini, M.
    Harmon, A. L.
    Ortendahl, J. D.
    VALUE IN HEALTH, 2018, 21 : S56 - S56
  • [45] Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan
    Kazuo Tamura
    Keisuke Aiba
    Toshiaki Saeki
    Yoichi Nakanishi
    Toshiharu Kamura
    Hideo Baba
    Kazuhiro Yoshida
    Nobuyuki Yamamoto
    Yuko Kitagawa
    Yoshihiko Maehara
    Mototsugu Shimokawa
    Koichi Hirata
    Masaki Kitajima
    International Journal of Clinical Oncology, 2017, 22 : 405 - 412
  • [46] REDUCTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) THROUGH TREATMENT WITH CLONAZEPAM
    Koga, Minako
    Nakadozono, Momoe
    Nukariya, Kazutaka
    Nogi, Hiroko
    Kobayashi, Tadashi
    Ochiai, Yusuke
    Nakayama, Kazuhiko
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3354 - 3354
  • [47] Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting
    Ruhlmann, Christina H.
    Herrstedt, Jorn
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (02) : 139 - 150
  • [48] Effectiveness of antiemetic in reducing chemotherapy-induced nausea and vomiting in adult patients; An oncology center experience
    Al-Salloum, Haya F.
    AL-Harbi, Hayat Eid
    Abdelazeem, Ahmed
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (06) : 1317 - 1325
  • [49] Chemotherapy-Induced Nausea and Vomiting (CINV) in Italian Lung Cancer Patients: Assessment by Physician, Nurse and Patient
    Carnio, Simona
    Galetta, Domenico
    Scotti, Vieri
    Cortinovis, Diego Luigi
    Antonuzzo, Andrea
    Pisconti, Salvatore
    Rossi, Antonio
    Martelli, Olga
    Lunghi, Alice
    Pilotto, Sara
    Del Conte, Alessandro
    Pegoraro, Valeria
    Montagna, Elisabetta Sara
    Topulli, Juliana
    Pelizzoni, Davide
    Rapetti, Simonetta Grazia
    Gianetta, Martina
    Pacchiana, Maria Vittoria
    Novello, Silvia
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S898 - S898
  • [50] Palonosetron for the prevention of chemotherapy-induced nausea and vomiting
    Mori-Vogt, Sherry
    Blazer, Marlo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (08) : 919 - 936
12345